Chryssostomos Chatgilialoglu was born in 1952 in Nikea (Greece) where he grew up and went to school until the age of 18. He went to Italy for University studies and received a doctorate degree in chemistry from the University of Bologna in 1976. In 1977, he moved to England for two years postdoctoral appointment at York University (1977-1979, Professor R.O.C. Norman) and in the end of 1979 he moved to Canada for three years as research associate at the National Research Council of Canada, Ottawa (1980-1982, Professor K.U. Ingold). In 1983, he joined the Consiglio Nazionale delle Ricerche (CNR) in Bologna (Italy) where he has been Research Director since 1991. In March 2014 he was appointed as the Director of the Institute of Nanoscience and Nanotechnology at the NCSR “Demokritos” in Athens (Greece) and from May 2015 he served as the vice-President of the NCSR “Demokritos”. In June 2016 he moved back to Bologna, to his Research Director position at ISOF-CNR. From February 2019, he is also Visiting Professor at the Center for Advanced Technologies, Adam Mickiewicz University, Poznan (Poland). In the end of 2019, he retired from CNR at the age of 67 years old and from February 2020 he is Research Associate at ISOF-CNR. He is Co-Founder and President of the spin-off company Lipinutragen.
He is the author or co-author of more than 300 publications in peer-reviewed journals (From Web of Science: over 11,000 citations, h-index 51), 34 book chapters, 6 patents, and 9 books (3 as author and 6 edited); Author of the monograph Organosilanes in Radical Chemistry, Wiley 2004; Co-editor of the Encyclopedia of Radicals in Chemistry, Biology and Materials (4 volumes), Wiley 2012; Co-author of the Membrane Lipidomics for Personalized Health, Wiley 2015.
The Chatgilialoglu’s research group is active in the field of free radical chemistry addressed to applications in life sciences. In the recent years, he developed biomimetic chemistry of radical stress and related biomarkers. The discovery of endogenous formation of trans-lipids, research on cyclopurine DNA lesions and fatty acid-based lipidomics attracted worldwide attention. He is responsible for introducing tris(trimethylsilyl)silane (TTMSS) as radical-based reducing agent and for this he was the winner of the Fluka Prize “Reagent of the Year 1990”.
For more information about the research activities, view chatgilialoglu-group
He had responsible functions within international projects, including Director of two NATO Advanced Study Institute on Sulfur-Centered Reactive Intermediates in Chemistry and Biology (June 1989) and on Chemical Synthesis: Gnosis to Prognosis (May 1994); Chairman of the COST Action CM0603 on Free Radicals in Chemical Biology (2007–2011) and of the COST Action CM1201 on Biomimetic Radical Chemistry (2013–2016); Principal Investigator in various Framework Programs of the European Commission, comprising Horizon 2020 projects: ClickGene (2015–2018); Supervisor of more than 15 PhD students and more than 30 Postdoctoral fellows, including three Marie Curie Intra-European Fellowships and three Marie Curie Research Training Networks.
He was invited as Guest-Editor for Special Issues in several scientific journals and invited speaker over 260 times at congresses and institutions.